ArticleTechnology in cancer research & treatment

Cetuximab-siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib.

K Sreedurgalakshmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.